Selvita books significant European biopharma order worth up to €5 million
Selvita SA (SLV) says it received a significant order from a European biopharmaceutical company worth up to €5 million.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.